Russian strike hits BadM pharmaceutical warehouse in Odesa — fourth such attack in September
Russian forces struck a warehouse of BadM, one of Ukraine's largest pharmaceutical distributors, in the Khadzhibey district of Odesa overnight on September 14. The premises suffered extensive damage and a fire broke out, with no reported casualties. The attack is the fourth Russian strike on a Ukrainian pharmaceutical warehouse since the start of September.
Key points
- Russian forces struck the BadM pharmaceutical warehouse in Odesa's Khadzhibey district overnight on September 14
- The premises suffered extensive damage and a fire, which emergency services are working to extinguish
- No casualties were reported, according to preliminary information
- BadM is one of Ukraine's largest pharmaceutical distributors; its 2025 revenue grew 5.7% to 72.2 billion hryvnias
- This is the fourth Russian attack on a Ukrainian pharmaceutical warehouse since the start of September
- September 3: the 45,000 sq. m Biokon logistics complex in Kyiv Oblast was destroyed, and the Teva Ukraine warehouse was struck twice
- September 12–13: the Universal Logistic complex in the Boryspil district, Ukraine's second-largest pharmaceutical warehouse, was damaged
Why it matters
BadM is one of Ukraine's largest pharmaceutical distributors, so damage to its facilities can have significant knock-on effects on medicine supply. The strike is the fourth Russian attack on a Ukrainian pharmaceutical warehouse since the beginning of September, following hits on Biokon, Teva Ukraine, and Universal Logistic — pointing to a pattern of targeting medicine supply infrastructure. Ukraine's Pharmacy Professional Association has warned of shrinking pharmacy warehouse stocks and advised the public to stockpile medicines for two to three months.
What happened
Russian forces struck a warehouse of pharmaceutical distributor BadM in the Khadzhibey district of Odesa overnight on September 14. The premises suffered extensive damage, and a fire broke out on the site, which Ukraine's State Emergency Service (DSNS) was working to extinguish. According to preliminary information, no one was injured.
BadM is one of the largest pharmaceutical distributors in Ukraine. The company is controlled by Dnipro-based businessmen Oleksandr Dytyatkovsky and Oleksandr Sukhodolsky, and its 2025 revenue grew 5.7% to 72.2 billion hryvnias.
The attack is the fourth Russian strike on a Ukrainian pharmaceutical warehouse since the start of September. On September 3, Russian forces destroyed the 45,000 sq. m Biokon logistics complex in the Boryspil district of Kyiv Oblast, which stored imported medicines from Pfizer, Novartis, Roche, and Teva, along with humanitarian cargo; damages are estimated in the billions of hryvnias. On the same day, the warehouse of Teva Ukraine was struck twice. On September 12–13, Russian forces attacked the Universal Logistic complex in the Boryspil district, described as Ukraine's second-largest pharmaceutical warehouse; the premises were damaged.
How Ukrainian sources describe it
All three supplied sources are Ukrainian-language media, framing the event explicitly as a Russian attack and emphasizing that the BadM strike is the fourth such attack on pharmaceutical warehouses since the start of September. The coverage highlights the scale of physical damage at BadM, the absence of casualties, and the target's identity as one of Ukraine's largest distributors. Ukrainian sources also foreground the systemic impact on medicine supply, citing the Pharmacy Professional Association's warning to stockpile medicines for two to three months, and listing prior attacks on Biokon, Teva Ukraine, Universal Logistic, and Optima-Pharm as part of a pattern.
Background
In October of the previous year, Russia struck a warehouse of Optima-Pharm, another of the two largest pharmaceutical distributors in Ukraine, destroying 20% of monthly medicine reserves. The Pharmacy Professional Association of Ukraine has warned of shrinking pharmaceutical warehouse stocks and advised the public to stockpile medicines for two to three months.